BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1778237)

  • 1. Serum chloride in the differential diagnosis of hypercalcemia.
    Lind L; Ljunghall S
    Exp Clin Endocrinol; 1991; 98(3):179-84. PubMed ID: 1778237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.
    Kvetny J; Orthman-Brask H; Frederiksen PK; Jest P; Jensen E; Jacobsen JG
    Acta Med Scand; 1982; 212(3):163-6. PubMed ID: 7148507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chloride/phosphate ratio in primary hyperparathyroidism.
    Boughey JC; Ewart CJ; Yost MJ; Nottingham JM; Brown JJ
    Am Surg; 2004 Jan; 70(1):25-8. PubMed ID: 14964541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis of hypercalcemia.
    Lafferty FW
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S51-9; discussion S61. PubMed ID: 1763670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential diagnosis of hypercalcemia by the chloride/phosphate ratio.
    Reeves CD; Palmer F; Bacchus H; Longerbeam JK
    Am J Surg; 1975 Aug; 130(2):166-71. PubMed ID: 1155729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological research on primary hyperparathyroidism. A prospective multicenter study].
    Niederle B; Roka R; Woloszczuk W; Schernthaner G; Schubert E; Borek E; Karner A; Hirsch E; Seidl F; Pesendorfer F
    Dtsch Med Wochenschr; 1988 Feb; 113(5):163-8. PubMed ID: 3338398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Performances of two kits for parathyroid hormone-related peptide (PTHrP) assay in the additional study of malignant hypercalcemias].
    Minebois-Villegas A; Audran M; Lortholary A; Legrand E; Boux De Casson-Raimbeau F; Jallet P
    Pathol Biol (Paris); 1995 Nov; 43(9):799-805. PubMed ID: 8746102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of ionized calcium in the diagnosis of subtle hypercalcemia in symptomatic primary hyperparathyroidism.
    McLeod MK; Monchik JM; Martin HF
    Surgery; 1984 Jun; 95(6):667-73. PubMed ID: 6729704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypercalcemia and primary hyperparathyroidism. Epidemiologic and diagnostic aspects].
    Woloszczuk W; Kovarik J; Puxkandl H
    Acta Med Austriaca; 1982; 9(5-6):201-4. PubMed ID: 7164756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential laboratory diagnosis of hypercalcemia.
    Johnson KR; Mascall GC; Howarth AT
    Crit Rev Clin Lab Sci; 1984; 21(1):51-97. PubMed ID: 6386333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical usefulness of the (chloride-90)/phosphate ratio for distinguishing primary hyperparathyroidism from hypercalcemia due to other causes.
    Higashi K; Morita M; Tajiri J; Sato T; Okazaki K; Arai S
    Endocrinol Jpn; 1985 Jun; 32(3):421-6. PubMed ID: 4042994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloride:phosphate ratio with hypercalcemia secondary to thiazide administration.
    Lawler FH; Janssen HP
    J Fam Pract; 1983 Jan; 16(1):153-4. PubMed ID: 6848626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiologic diagnosis of hypercalcemia. A study of 100 cases].
    Dupont P; Fuss M; Corvilain J
    Rev Rhum Mal Osteoartic; 1978; 45(7-9):491-7. PubMed ID: 725466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassays for parathyroid hormone 1-84 in the diagnosis of hyperparathyroidism.
    Nussbaum SR; Potts JT
    J Bone Miner Res; 1991 Oct; 6 Suppl 2():S43-50; discussion S61. PubMed ID: 1722383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical approach to hypercalcemia.
    Carroll MF; Schade DS
    Am Fam Physician; 2003 May; 67(9):1959-66. PubMed ID: 12751658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Chloride-phosphate ratio in hypercalcemia.
    Pieroni RE
    N Engl J Med; 1974 Sep; 291(10):531-2. PubMed ID: 4852721
    [No Abstract]   [Full Text] [Related]  

  • 17. Contribution of parathyroid hormone-related peptide to the evaluation of hypercalcemia.
    Audran M; Minebois-Villégas A; Lortholary A; Legrand E; Pascaretti C; Giraud P; Subra JF; Boasson M; Jallet P
    Rev Rhum Engl Ed; 1995 Mar; 62(3):189-96. PubMed ID: 7788336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Approach to examining hypercalcemia in the clinical laboratory].
    Shirata T; Fukuyama H; Miura H; Suwabe A; Tominaga M
    Rinsho Byori; 1999 Dec; 47(12):1140-7. PubMed ID: 10639824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypercalcemia and neoplasms].
    Rossetti A; Taliani U; Pioli G; Sansoni P
    G Clin Med; 1987; 68(6-7):335-8, 340-5. PubMed ID: 2888700
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of nonparametric recursive partitioning to parametric discriminant analyses in laboratory differentiation of hypercalcemia.
    Lacher DA
    Clin Chim Acta; 1991 Dec; 204(1-3):199-207. PubMed ID: 1819462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.